Literature DB >> 22373837

Novel nonsense mutation of ABHD5 in Dorfman-Chanarin syndrome with unusual findings: a challenge for genotype-phenotype correlation.

Shagun Aggarwal1, Jaswinder Singh Maras, Seema Alam, Rajeev Khanna, Sanjeev Kumar Gupta, Arvind Ahuja.   

Abstract

Dorfman-Chanarin syndrome is a rare neutral lipid disorder characterised by icthyosis, hepatic steatosis and multisystemic involvement of varying magnitude. It is an autosomal recessive disease caused by mutations in the ABHD5 gene. We report a consanguineous family of Afgani origin, with four affected siblings who were found to have a novel homozygous nonsense mutation g. [27606 G > T]; [27606 G > T]. The clinical findings were unusual in the form of early cirrhosis and hepatic decompensation in one sibling, presence of corneal opacities in male siblings and tessellated fundus in all affected children. Steatosis was minimal in liver biopsy specimens and all children had low vitamin D levels. Genotype-phenotype correlations have not been possible in Dorfman-Chanarin syndrome and the present report raises further challenges for the same.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22373837     DOI: 10.1016/j.ejmg.2012.01.013

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  9 in total

Review 1.  CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis.

Authors:  Liqing Yu; Yi Li; Alison Grisé; Huan Wang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 2.  Comparative gene identification-58/α/β hydrolase domain 5: more than just an adipose triglyceride lipase activator?

Authors:  Kathrin A Zierler; Rudolf Zechner; Guenter Haemmerle
Journal:  Curr Opin Lipidol       Date:  2014-04       Impact factor: 4.776

3.  Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*).

Authors:  Rita Quelhas da Costa; Francisco Laranjeira; Isaura Duarte Ribeiro; António Filipe Santos; Filipe Nery
Journal:  GE Port J Gastroenterol       Date:  2021-07-07

4.  ABHD5 frameshift deletion in Golden Retrievers with ichthyosis.

Authors:  Sarah Kiener; Dominique J Wiener; Kaitlin Hopke; Alison B Diesel; Vidhya Jagannathan; Elizabeth A Mauldin; Margret L Casal; Tosso Leeb
Journal:  G3 (Bethesda)       Date:  2022-02-04       Impact factor: 3.542

5.  Recurrent N209* ABHD5 mutation in two unreported families with Chanarin Dorfman Syndrome.

Authors:  Daniela Tavian; Murat Durdu; Corrado Angelini; Enza Torre; Sara Missaglia
Journal:  Eur J Transl Myol       Date:  2021-05-12

6.  Structural and functional insights into ABHD5, a ligand-regulated lipase co-activator.

Authors:  Yan Yuan Tseng; Matthew A Sanders; Huamei Zhang; Li Zhou; Chia-Yi Chou; James G Granneman
Journal:  Sci Rep       Date:  2022-02-16       Impact factor: 4.379

7.  Case Report: Chanarin-Dorfman Syndrome: A Novel Homozygous Mutation in ABHD5 Gene in a Chinese Case and Genotype-Phenotype Correlation Analysis.

Authors:  Bo Liang; He Huang; Jiaxiang Zhang; Gang Chen; Xiangsheng Kong; Mengting Zhu; Peiguang Wang; Lili Tang
Journal:  Front Genet       Date:  2022-03-28       Impact factor: 4.599

8.  Early onset of Chanarin-Dorfman syndrome with severe liver involvement in a patient with a complex rearrangement of ABHD5 promoter.

Authors:  Sara Missaglia; Eugenia Ribeiro Valadares; Laura Moro; Eleonora Druve Tavares Faguntes; Raquel Quintão Roque; Bruno Giardina; Daniela Tavian
Journal:  BMC Med Genet       Date:  2014-03-14       Impact factor: 2.103

9.  A novel mutation of ABHD5 gene in a Chanarin Dorfman patient with unusual dermatological findings.

Authors:  Ali Haydar Eskiocak; Sara Missaglia; Laura Moro; Murat Durdu; Daniela Tavian
Journal:  Lipids Health Dis       Date:  2019-12-28       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.